-+ 0.00%
-+ 0.00%
-+ 0.00%

IOVANCE PRESENTS NEW DATA AT ESMO 2026 DEMONSTRATING DEEP, DURABLE RESPONSES WITH LIFILEUCEL TIL CELL THERAPY PLUS PEMBROLIZUMAB IN FRONTLINE ADVANCED MELANOMA

Reuters·10/23/2026 14:15:00

Please log in to view news